Skip to main content
. Author manuscript; available in PMC: 2013 Oct 2.
Published in final edited form as: Ann Surg Oncol. 2011 Jun 7;19(1):225–232. doi: 10.1245/s10434-011-1823-z

TABLE 1.

Clinicopathologic characteristics for 7509 SLN procedures in 7302 patients, by use of FS

Characteristic SLN/no FS (n = 1182), n (%) SLN/FS (n = 6327), n (%) P valuea
Median age, year (range) 59 (12–90) 56 (19–91) < 0.001
Operation < 0.001
 Breast conservation 857 (72.6) 4227 (66.9)
 Mastectomy 323 (27.4) 2093 (33.1)
 Missing 2 7
Median tumor size, cm (range) 0.7 (0.1–5.0) 1.3 (0.1–17.0) < 0.001
Tumor size < 0.001
 T1 (≤2 cm) 1084 (93.1) 4893 (78.9)
 T2 (2–5 cm) 80 (6.9) 1250 (20.2)
 T3 (> 5 cm) 0 (0.0) 59 (1.0)
 Tx (unknown) 18 125
Histologic grade < 0.001
 I 123 (13.8) 391 (7.3)
 II 281 (31.5) 1575 (29.6)
 III 489 (54.8) 3362 (63.1)
 Unknown 289 999
Nuclear grade < 0.001
 I 100 (11.9) 329 (6.4)
 II 497 (59.2) 2832 (55.0)
 III 243 (28.9) 1986 (38.6)
 Unknown 342 1180
Positive SLN 216 (18.3) 2219 (35.1) < 0.001
LVI
 Present 161 (14.3) 1554 (24.9) < 0.001
 Missing 60 84
Multicentric/multifocal tumor
 Present 280 (23.7) 1502 (23.7) 1.000
 Missing 1 2
ER positive
 Present 852 (81.5) 4584 (80.2) 0.330
 Missing 137 611
PR positive
 Present 621 (59.8) 3395 (59.7) 1.000
 Missing 143 643
Tumor type < 0.001b
 Invasive ductal 907 (76.8) 5323 (84.2)
 Invasive lobular 96 (8.1) 684 (10.8)
 Microinvasive DCIS 148 (12.5) 96 (1.5)
 Other invasive carcinomas 11 (0.9) 94 (1.5)
 Invasive carcinoma with ductal and lobular features 19 (1.6) 128 (2.0)
 Missing 1 2
Median year of surgery (range) 2005 (1997–2006) 2002 (1997–2006) < 0.001

SLN sentinel lymph node, FS frozen section, LVI lymphovascular invasion, ER estrogen receptor, PR progesterone receptor, DCIS ductal carcinoma in situ

a

All P values are based on Fisher’s exact test (categorical covariates) or Wilcoxon rank sum test (continuous covariates), except where otherwise indicated

b

This P value is based on Pearson’s chi-square test